Elsevier

Microvascular Research

Volume 89, September 2013, Pages 122-128
Microvascular Research

Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database

https://doi.org/10.1016/j.mvr.2013.06.003Get rights and content

Highlights

  • This is the largest multicenter international study on SSc and capillaroscopy.

  • Capillaroscopic patterns are directly related to the extent of organ involvement.

  • Capillaroscopy is of great value for an early diagnosis of SSc and in monitoring the disease course.

Abstract

Objective

The aims of this study were to obtain cross-sectional data on capillaroscopy in an international multi-center cohort of Systemic Sclerosis (SSc) and to investigate the frequency of the capillaroscopic patterns and their disease-phenotype associations.

Methods

Data collected between June 2004 and October 2011 in the EULAR Scleroderma Trials and Research (EUSTAR) registry were examined. Patients' profiles based on clinical and laboratory data were obtained by cluster analysis and the association between profiles and capillaroscopy was investigated by multinomial logistic regression.

Results

62 of the 110 EUSTAR centers entered data on capillaroscopy in the EUSTAR database. 376 of the 2754 patients (13.65%) were classified as scleroderma pattern absent, but non-specific capillary abnormalities were noted in 55.48% of the cases. Four major patients' profiles were identified characterized by a progressive severity for skin involvement, as well as an increased number of systemic manifestations. The “early” and “active” scleroderma patterns were generally observed in patients with mild/moderate skin involvement and a low number of disease manifestations, while the “late” scleroderma pattern was found more frequently in the more severe forms of the disease.

Conclusion

These data indicate the importance of capillaroscopy in SSc management and that capillaroscopic patterns are directly related to the extent of organ involvement.

Introduction

Systemic sclerosis (SSc) is a severe connective tissue disease in which vascular dysfunction, tissue fibrosis and immune dysregulation are key events. SSc has a heterogeneous clinical presentation, but skin and vascular changes are the hallmark of the disease (Geyer and Muller-Ladner, 2011, Herrick, 2012). Pathological microvascular findings in SSc document a significant loss of the peripheral vascular network, with loss of capillaries, deficient vascular repair and the absence of new vessel growth, and subsequent tissue ischemia and fibrosis (Brown and O'Leary, 1925, Herrick and Cutolo, 2010, Kuwana et al., 2004).

The sequence of these alterations in the microcirculation can be observed using a reliable, rapid, non-invasive examination such as nailfold capillaroscopy, which can be regarded as the most valuable technique for assisting the early diagnosis of SSc and monitoring the evolution of microangiopathy in overt SSc (Avouac et al., 2011, Cutolo et al., 2010). Capillaroscopy is a powerful in vivo tool not only in screening patients with Raynaud's phenomenon for underlying scleroderma spectrum disorders (Ingegnoli et al., 2008, Ingegnoli et al., 2010, Nagy and Czirjak, 2004, Vayssairat et al., 1982), but also in detecting the progressive microvascular damage during the course of SSc (Herrick and Cutolo, 2010).

The distinctive and identifiable morphological nailfold changes observed in patients with SSc have been extensively studied; they include enlarged loops, giant capillaries, neovascularization, capillary loss, and disrupted architecture of the nailfold microvascular network (Bukhari et al., 1996, Herrick and Cutolo, 2010, Herrick et al., 2010, Maricq and LeRoy, 1973, Maricq et al., 1980, Maricq et al., 1983). These microvascular scleroderma specific capillaroscopy abnormalities were initially described by Maricq (Maricq et al., 1980, Maricq et al., 1983) and called “scleroderma patterns”; subsequently they were classified into 3 different patterns, which include an “early” pattern (i.e. few enlarged/giant capillaries, few capillary hemorrhages, no evident loss of capillaries), an “active” pattern (i.e. frequent giant capillaries, frequent capillary hemorrhages, mild disorganization of the capillary network), and a “late” pattern (i.e. irregular enlargement of the capillaries, few or absent giant capillaries, hemorrhages, and extensive avascular areas) (Cutolo et al., 2000).

In order to clarify with further aspects the reported associations between nailfold capillary abnormalities and clinical and/or laboratory features (Bredemeier et al., 2004, Caramaschi et al., 2007, Chen et al., 1984, Cutolo et al., 2004, Hofstee et al., 2009, Lovy et al., 1985, Smith et al., 2012, Sulli et al., 2012) it was decided to evaluate a large multi-national group of patients with SSc such as the international multicenter cohort of the EULAR Scleroderma Trials And Research (EUSTAR) registry.

Therefore, the steps of this cross-sectional study were:

  • -

    To ascertain the use of capillaroscopy in everyday practice in the EUSTAR centers. Due to the fact that data on capillaroscopy were not mandatory points in the database, a lot of missing data on this topic were present. Therefore, EUSTAR centers were invited to give additional information by a short survey for assessing whether and how capillaroscopy is performed.

  • -

    To define a proper target population and to evaluate if the sample of patients in the study was representative of the population. After completing as much as possible the missing information, the target population was identified with inclusion and exclusion criteria. The representativity of the sample studied was evaluated comparing the characteristics of patients with and without information on capillaroscopy.

  • -

    To determine the frequency of capillaroscopic patterns (i.e. scleroderma pattern vs non-scleroderma pattern) in adult SSc patients, and to identify disease-phenotype associations. For this purpose clinical and demographic characteristics of patients with and without scleroderma pattern were compared.

  • -

    To examine the prevalence of the three different scleroderma patterns (i.e. early, active or late) and to better characterize these patterns in terms of their association with disease measurements, clinical and laboratory features. With this aim clinical and demographic characteristics of patients with early, active or late scleroderma pattern were compared.

  • -

    To evaluate jointly the association between clinical/laboratory information and capillaroscopic patterns. For this purpose, firstly groups (profiles) of patients which were homogeneous for their clinical/laboratory characteristics were obtained by cluster analysis; thus, these patients' profiles were related with capillaroscopy data.

Section snippets

The EUSTAR database

This EUSTAR study on capillaroscopy is based on data collected from the SSc patients entered in the EUSTAR registry. This database was launched in June 2004 and documents a multi-national, prospective and open SSc cohort. Participating medical centers have entered the data of consecutive patients into a specific database, which was definitely locked for this study in October 2011. The structure and minimal essential dataset (MEDS) of the EUSTAR database have been previously described (Tyndall

Use of nailfold capillaroscopy

A short survey was undertaken to collect information on capillaroscopy and response rate was 33.6% (37 of 110 centers), of whom 91.4% are European centers. In 18.9% (7 of 37) capillaroscopy was not routinely assessed, whereas in the 67.6% (25 of 37) of cases capillaroscopy was performed but data were not reported in the EUSTAR database. In 10 of 37 (27.0%) centers, capillaroscopy technique had been recently introduced and a videocapillaroscopic equipment was available only in 26 of 37 (70.3%)

Discussion

In the context of a constant chase for identifying a useful non-invasive tool to monitor SSc, the results of this large study on capillaroscopy add important information concerning the actual role of capillaroscopy.

The first part of this study aimed to depict the use of capillaroscopy in clinical practice. A low adherence to the survey was observed, but the collected data confirm that this technique is particularly used in European countries. This diagnostic tool was only recently introduced in

Acknowledgment

László Czirják Department of Immunology and Rheumatology, Faculty of Medicine, University of Pécs, Akác u.l., Hungary; Montecucco, Unita' Operativa e Cattedra di Reumatologia IRCCS Policlinico S Matteo, Pavia, Italy; Eugene J. Kucharz Department of Internal Medicine and Rheumatology, Medical University of Silesia, Katowice, Poland; Blaz Rozman University Medical Center Ljublijana, Division of Internal Medicine, Department of Rheumatology, Ljubliana, Slovenia; Armando Gabrielli Istituto di

References (45)

  • M. Bukhari

    Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy

    Rheumatology (Oxford)

    (2000)
  • P. Caramaschi

    Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity

    Rheumatology (Oxford)

    (2007)
  • M. Cutolo

    Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis

    J. Rheumatol.

    (2000)
  • M. Cutolo

    Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis

    Rheumatology (Oxford)

    (2004)
  • M. Cutolo

    Assessing microvascular changes in systemic sclerosis diagnosis and management

    Nat. Rev. Rheumatol.

    (2010)
  • M. Cutolo

    Training in capillaroscopy: a growing interest

    J. Rheumatol.

    (2012)
  • R. De Angelis

    A growing need for capillaroscopy in rheumatology

    Arthritis Rheum.

    (2009)
  • M. Geyer et al.

    The pathogenesis of systemic sclerosis revisited

    Clin. Rev. Allergy Immunol.

    (2011)
  • M.J. Greenacre

    Correspondence Analysis in Practice

    (1993)
  • A.L. Herrick

    The pathogenesis, diagnosis and treatment of Raynaud phenomenon

    Nat. Rev. Rheumatol.

    (2012)
  • A.L. Herrick et al.

    Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis

    Arthritis Rheum.

    (2010)
  • A.L. Herrick

    Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia

    Rheumatology (Oxford)

    (2010)
  • Cited by (91)

    • Nailfold capillaroscopy

      2023, Best Practice and Research: Clinical Rheumatology
    View all citing articles on Scopus
    View full text